Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GRPH | Common Stock | Conversion of derivative security | +6.17M | 6.17M | Jun 29, 2021 | By Fund | F1, F2 | |||
transaction | GRPH | Common Stock | Conversion of derivative security | +741K | +12.02% | 6.91M | Jun 29, 2021 | By Fund | F1, F2 | ||
transaction | GRPH | Common Stock | Conversion of derivative security | +22.8K | 22.8K | Jun 29, 2021 | By Fund | F1, F3 | |||
transaction | GRPH | Common Stock | Purchase | $8.25M | +485K | +7.02% | $17.00 | 7.39M | Jun 29, 2021 | By Fund | F2 |
transaction | GRPH | Common Stock | Purchase | $255K | +15K | +65.93% | $17.00 | 37.8K | Jun 29, 2021 | By Fund | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GRPH | Series A Redeemable Convertible Preferred Stock | Conversion of derivative security | $0 | -15M | -100% | $0.00* | 0 | Jun 29, 2021 | Common Stock | 6.17M | By Fund | F1, F2 | |
transaction | GRPH | Series B Redeemable Convertible Preferred Stock | Conversion of derivative security | $0 | -1.8M | -100% | $0.00* | 0 | Jun 29, 2021 | Common Stock | 741K | By Fund | F1, F2 | |
transaction | GRPH | Series B Redeemable Convertible Preferred Stock | Conversion of derivative security | $0 | -55.3K | -100% | $0.00* | 0 | Jun 29, 2021 | Common Stock | 22.8K | By Fund | F1, F3 |
Id | Content |
---|---|
F1 | Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a one-for-2.432 basis, and had no expiration date. |
F2 | Shares held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein. |
F3 | Shares held by 436, L.P. ("436 LP"). 436, LLC ("436 LLC") is the general partner of 436 LP and may be deemed to beneficially own the shares held by 436 LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by 436 LP and, accordingly, may be deemed to beneficially own the shares held by 436 LP. Each of 436 LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein. |